178 related articles for article (PubMed ID: 32318954)
1. Carbon ion radiation therapy in breast cancer: a new frontier.
Malouff TD; Mahajan A; Mutter RW; Krishnan S; Hoppe BS; Beltran C; Trifiletti DM; Vallow LA
Breast Cancer Res Treat; 2020 Jun; 181(2):291-296. PubMed ID: 32318954
[TBL] [Abstract][Full Text] [Related]
2. Carbon ion radiotherapy in the treatment of gliomas: a review.
Malouff TD; Peterson JL; Mahajan A; Trifiletti DM
J Neurooncol; 2019 Nov; 145(2):191-199. PubMed ID: 31571113
[TBL] [Abstract][Full Text] [Related]
3. First experience of carbon-ion radiotherapy for early breast cancer.
Akamatsu H; Karasawa K; Omatsu T; Isobe Y; Ogata R; Koba Y
Jpn J Radiol; 2014 May; 32(5):288-95. PubMed ID: 24615166
[TBL] [Abstract][Full Text] [Related]
4. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
6. Carbon Ion Therapy: A Modern Review of an Emerging Technology.
Malouff TD; Mahajan A; Krishnan S; Beltran C; Seneviratne DS; Trifiletti DM
Front Oncol; 2020; 10():82. PubMed ID: 32117737
[TBL] [Abstract][Full Text] [Related]
7. A Phase I clinical trial of carbon ion radiotherapy for Stage I breast cancer: clinical and pathological evaluation.
Karasawa K; Omatsu T; Arakawa A; Yamamoto N; Ishikawa T; Saito M; Fukuda S; Kamada T;
J Radiat Res; 2019 May; 60(3):342-347. PubMed ID: 30805611
[TBL] [Abstract][Full Text] [Related]
8. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum.
Shinoto M; Yamada S; Okamoto M; Shioyama Y; Ohno T; Nakano T; Nemoto K; Isozaki Y; Kawashiro S; Tsuji H; Kamada T
Radiother Oncol; 2019 Mar; 132():236-240. PubMed ID: 30360998
[TBL] [Abstract][Full Text] [Related]
9. Hadrontherapy techniques for breast cancer.
Loap P; De Marzi L; Almeida CE; Barcellini A; Bradley J; de Santis MC; Dendale R; Jimenez R; Orlandi E; Kirova Y
Crit Rev Oncol Hematol; 2022 Jan; 169():103574. PubMed ID: 34958916
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cells.
Konings K; Belmans N; Vermeesen R; Baselet B; Lamers G; Janssen A; Isebaert S; Baatout S; Haustermans K; Moreels M
Int J Oncol; 2019 Dec; 55(6):1339-1348. PubMed ID: 31638201
[TBL] [Abstract][Full Text] [Related]
11. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
12. Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review.
Malouff TD; Krishnan S; Hallemeier CL; Haddock MG; Hoppe BS; Beltran C; Mahajan A; Trifiletti DM
Pancreas; 2020 Jul; 49(6):737-743. PubMed ID: 32590617
[TBL] [Abstract][Full Text] [Related]
13. Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce.
Vogin G; Wambersie A; Pötter R; Beuve M; Combs SE; Magrin G; Mayer R; Mock U; Sarrut D; Schreiner T; Fossati P; Balosso J
Cancer Radiother; 2018 Dec; 22(8):802-809. PubMed ID: 30327228
[TBL] [Abstract][Full Text] [Related]
14. Proton and carbon ion radiation therapy for locally advanced pancreatic cancer: A phase I dose escalation study.
Yu Z; Hong Z; Zhang Q; Lin LC; Shahnazi K; Wu X; Lu J; Jiang G; Wang Z
Pancreatology; 2020 Apr; 20(3):470-476. PubMed ID: 32033896
[TBL] [Abstract][Full Text] [Related]
15. Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Ikawa H; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):353-361. PubMed ID: 30191869
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
17. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702".
Kawamura H; Kubo N; Sato H; Mizukami T; Katoh H; Ishikawa H; Ohno T; Matsui H; Ito K; Suzuki K; Nakano T;
BMC Cancer; 2020 Jan; 20(1):75. PubMed ID: 32000716
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
Kawashiro S; Yamada S; Okamoto M; Ohno T; Nakano T; Shinoto M; Shioyama Y; Nemoto K; Isozaki Y; Tsuji H; Kamada T
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1212-1221. PubMed ID: 29907490
[TBL] [Abstract][Full Text] [Related]
19. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
